FINANCIAL CONSULATE, INC Axsome Therapeutics, Inc. Transaction History

FINANCIAL CONSULATE, INC portfolio value:

$233,000
portfolio value

FINANCIAL CONSULATE, INC quarter portfolio value change:

+16.50%
quarter

Axsome Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 33K $44.62 5.22K
Q2 2022 share Increase +7.30% 355 shares -1K $38.3 5.22K
Q1 2022 share Increase 0.00% 4.86K shares 201K $41.39 4.86K